Resultados de procura - Paul R. Fortin

Limitar resultados
  1. 1
    Effect of Nicotinamide in Skin Cancer and Actinic Keratoses Chemoprophylaxis, and Adverse Effects Related to Nicotinamide: A Systematic Review and Meta-Analysis

    Effect of Nicotinamide in Skin Cancer and Actinic Keratoses Chemoprophylaxis, and Adverse Effects Related to Nicotinamide: A Systematic Review and Meta-Analysis por Laurence Mainville, Anne-Sophie Smilga, Paul R. Fortin

    Publicado 2022
    Ligazón do recurso Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  2. 2
    Approaches for estimating minimal clinically important differences in systemic lupus erythematosus

    Approaches for estimating minimal clinically important differences in systemic lupus erythematosus por K. Sharan, Jinoos Yazdany, Paul R. Fortin, J. Antonio Aviña‐Zubieta

    Publicado 2015
    Ligazón do recurso
    Revisão
    Engadir a favoritos
    Gardado en:
  3. 3
    The Early Protective Effect of Hydroxychloroquine on the Risk of Cumulative Damage in Patients with Systemic Lupus Erythematosus

    The Early Protective Effect of Hydroxychloroquine on the Risk of Cumulative Damage in Patients with Systemic Lupus Erythematosus por Pooneh Akhavan, Jiandong Su, Wendy Lou, Dafna D. Gladman, Murray B. Urowitz, Paul R. Fortin

    Publicado 2013
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  4. 4
    Unpacking Early Work Experiences of Young Adults With Rheumatic Disease: An Examination of Absenteeism, Job Disruptions, and Productivity Loss

    Unpacking Early Work Experiences of Young Adults With Rheumatic Disease: An Examination of Absenteeism, Job Disruptions, and Productivity Loss por Arif Jetha, Elizabeth M. Badley, Dorcas Beaton, Paul R. Fortin, Natalie J. Shiff, Monique A. M. Gignac

    Publicado 2015
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  5. 5
    Occupational and environmental exposures and risk of systemic lupus erythematosus: silica, sunlight, solvents

    Occupational and environmental exposures and risk of systemic lupus erythematosus: silica, sunlight, solvents por GS Cooper, Joan Wither, Sasha Bernatsky, Jaime O. Claudio, Ann E. Clarke, John D. Rioux, Paul R. Fortin

    Publicado 2010
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  6. 6
    Designing an intervention for women with systemic lupus erythematosus from medically underserved areas to improve care: a qualitative study

    Designing an intervention for women with systemic lupus erythematosus from medically underserved areas to improve care: a qualitative study por CH Feldman, BL Bermas, Melanie J. Zibit, Patricia A. Fraser, DJ Todd, Paul R. Fortin, Elena Massarotti, KH Costenbader

    Publicado 2012
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  7. 7
    The baseline interferon signature predicts disease severity over the subsequent 5 years in systemic lupus erythematosus

    The baseline interferon signature predicts disease severity over the subsequent 5 years in systemic lupus erythematosus por Lloyd Mai, Arundip Asaduzzaman, Babak Noamani, Paul R. Fortin, Dafna D. Gladman, Zahi Touma, Murray B. Urowitz, Joan Wither

    Publicado 2021
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  8. 8
    Expanded Population of Activated Antigen-Engaged Cells within the Naive B Cell Compartment of Patients with Systemic Lupus Erythematosus

    Expanded Population of Activated Antigen-Engaged Cells within the Naive B Cell Compartment of Patients with Systemic Lupus Erythematosus por Nan‐Hua Chang, Tamara McKenzie, Gabriel Bonventi, Carolina Landolt-Marticorena, Paul R. Fortin, Dafna D. Gladman, Murray B. Urowitz, Joan Wither

    Publicado 2008
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  9. 9
    A Controlled Study of Diffuse Idiopathic Skeletal Hyperostosis Clinical Features and Functional Status

    A Controlled Study of Diffuse Idiopathic Skeletal Hyperostosis Clinical Features and Functional Status por Sonia Mata, Paul R. Fortin, Mary‐Ann Fitzcharles, Michael Starr, Lawrence Joseph, Craig S. Watts, Brian F. Gore, Ellen Rosenberg, Rethy Chhem, John M. Esdaile

    Publicado 1997
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  10. 10
    Autoantibodies in Systemic Lupus Erythematosus Target Mitochondrial RNA

    Autoantibodies in Systemic Lupus Erythematosus Target Mitochondrial RNA por Yann Becker, Geneviève Marcoux, Isabelle Allaeys, Anne‐Sophie Julien, Renée-Claude Loignon, Hadrien Benk-Fortin, Emmanuelle Rollet‐Labelle, Joyce Rauch, Paul R. Fortin, Éric Boilard

    Publicado 2019
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  11. 11
    Anti-nucleosome antibodies outperform traditional biomarkers as longitudinal indicators of disease activity in systemic lupus erythematosus

    Anti-nucleosome antibodies outperform traditional biomarkers as longitudinal indicators of disease activity in systemic lupus erythematosus por Tingting Li, Stephenie D. Prokopec, S. Morrison, Wendy Lou, Heather N. Reich, Dafna D. Gladman, Murray B. Urowitz, J. W. Scholey, Paul R. Fortin, Paul C. Boutros, Joan Wither, Carolina Landolt-Marticorena

    Publicado 2014
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  12. 12
    Identification of a neutrophil-related gene expression signature that is enriched in adult systemic lupus erythematosus patients with active nephritis: Clinical/pathologic associations and etiologic mechanisms

    Identification of a neutrophil-related gene expression signature that is enriched in adult systemic lupus erythematosus patients with active nephritis: Clinical/pathologic associat... por Joan Wither, Stephenie D. Prokopec, Babak Noamani, Nan‐Hua Chang, Dennisse Bonilla, Zahi Touma, Carmen Ávila-Casado, Heather N. Reich, James W. Scholey, Paul R. Fortin, Paul C. Boutros, Carolina Landolt-Marticorena

    Publicado 2018
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  13. 13
    The 1000 Canadian Faces of Lupus: Determinants of Disease Outcome in a Large Multiethnic Cohort

    The 1000 Canadian Faces of Lupus: Determinants of Disease Outcome in a Large Multiethnic Cohort por Christine Peschken, Steven J. Katz, Earl D. Silverman, Janet Pope, Paul R. Fortin, Christian A. Pineau, C. Douglas Smith, Hector Arbillaga, Dafna D. Gladman, Murray B. Urowitz, Michel Zummer, Ann E. Clarke, Sasha Bernatsky, Marie Hudson

    Publicado 2009
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  14. 14
    Persistent proteinuria and dyslipidemia increase the risk of progressive chronic kidney disease in lupus erythematosus

    Persistent proteinuria and dyslipidemia increase the risk of progressive chronic kidney disease in lupus erythematosus por Heather N. Reich, Dafna D. Gladman, Murray B. Urowitz, Joanne M. Bargman, Michelle Hladunewich, Wendy Lou, Steve Fan, Jiandong Su, Andrew M. Herzenberg, Daniel C. Cattran, Joan Wither, Carol Landolt-Marticorena, James W. Scholey, Paul R. Fortin

    Publicado 2011
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  15. 15
    Evaluation of Clinical Outcomes and Renal Vascular Pathology among Patients with Lupus

    Evaluation of Clinical Outcomes and Renal Vascular Pathology among Patients with Lupus por Claire Barber, Andrew M. Herzenberg, Ellie Aghdassi, Jiandong Su, Wendy Lou, Qian Gan, Jonathan Yip, Samih H. Nasr, David B. Thomas, James W. Scholey, Joan Wither, Murray Urowitz, Dafna D. Gladman, Heather N. Reich, Paul R. Fortin

    Publicado 2012
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  16. 16
    Early medication use in new-onset rheumatoid arthritis may delay joint replacement: results of a large population-based study

    Early medication use in new-onset rheumatoid arthritis may delay joint replacement: results of a large population-based study por Cristiano Soares de Moura, Michał Abrahamowicz, Marie‐Eve Beauchamp, Diane Lacaille, Yishu Wang, Gilles Boire, Paul R. Fortin, Louis Bessette, Claire Bombardier, Jessica Widdifield, John G. Hanly, Debbie Ehrmann Feldman, Walter P. Maksymowych, Christine Peschken, Cheryl Barnabé, S M Edworthy, Sasha Bernatsky

    Publicado 2015
    Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  17. 17
    Platelets Disseminate Extracellular Vesicles in Lymph in Rheumatoid Arthritis

    Platelets Disseminate Extracellular Vesicles in Lymph in Rheumatoid Arthritis por Nicolas Tessandier, Imène Melki, Nathalie Cloutier, Isabelle Allaeys, Adam Miszta, Sisareuth Tan, Andreea Milasan, Sara Michel, Abderrahim Benmoussa, Tania Lévesque, Francine Côté, Steven E. McKenzie, Caroline Gilbert, Patrick Provost, Alain Brisson, Alisa S. Wolberg, Paul R. Fortin, Catherine Martel, Éric Boilard

    Publicado 2020
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  18. 18
    Pregnancy outcomes in antiphospholipid antibody positive patients: prospective results from the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository (‘Registry’)

    Pregnancy outcomes in antiphospholipid antibody positive patients: prospective results from the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking... por Zeynep Belce Erton, Ecem Sevim, Guilherme Ramires de Jesús, Ricard Cervera, Lanlan Ji, Vittorio Pengo, Amaia Ugarte, Danieli Andrade, Laura Andréoli, T Atsumi, Paul R. Fortin, Maria Gerosa, Yu Zuo, Michelle Petri, Savino Sciascia, Maria G. Tektonidou, M. Á. Aguirre, D. Ware Branch, Doruk Erkan

    Publicado 2022
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  19. 19
    Fluctuation of Anti–Domain 1 and Anti–<scp>β<sub>2</sub>‐Glycoprotein</scp> I Antibody Titers Over Time in Patients With Persistently Positive Antiphospholipid Antibodies

    Fluctuation of Anti–Domain 1 and Anti–<scp>β<sub>2</sub>‐Glycoprotein</scp> I Antibody Titers Over Time in Patients With Persistently Positive Antiphospholipid Antibodies por Cecilia Beatrice Chighizola, Francesca Pregnolato, Danieli Andrade, Maria G. Tektonidou, Vittorio Pengo, Guillermo Ruiz‐Irastorza, H. Michael Belmont, Maria Gerosa, Paul R. Fortin, D. Ware Branch, Laura Andréoli, Michelle Petri, Ricard Cervera, Jason S. Knight, Rohan Willis, Maria Efthymiou, Hannah Cohen, Doruk Erkan, María Laura Bertolaccini

    Publicado 2023
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:
  20. 20
    A Comparison of Two Intensities of Warfarin for the Prevention of Recurrent Thrombosis in Patients with the Antiphospholipid Antibody Syndrome

    A Comparison of Two Intensities of Warfarin for the Prevention of Recurrent Thrombosis in Patients with the Antiphospholipid Antibody Syndrome por Mark Crowther, Jeff Ginsberg, Jim A. Julian, Judah A. Denburg, Jack Hirsh, James D. Douketis, Carl A. Laskin, Paul R. Fortin, David R. Anderson, Clive Kearon, Ann E. Clarke, William Geerts, Melissa Forgie, David Green, Lorrie Costantini, Wendy Yacura, Sarah Wilson, Michael Gent, Michael J. Kovacs

    Publicado 2003
    Ligazón do recurso Ligazón do recurso
    Artigo
    Engadir a favoritos
    Gardado en:

Ferramentas de procura: